anyone buying at this level will regret big time..
" A preliminary analysis indicates that the study is unlikely to meet its predefined
endpoints for diagnosis of childhood respiratory disease with the lower bound of the
95% confidence interval of both PPA and NPA with clinical diagnosis being below 75% of
all diseases. The most promising result was for bronchiolitis, which achieved an 80%"
G A M E O V E R - time to run away and stay away...this is yellow snow.
- Forums
- ASX - By Stock
- RAP
- Ann: Preliminary Top-line Results from SMARTCOUGH-C Study
Ann: Preliminary Top-line Results from SMARTCOUGH-C Study, page-137
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 273 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)